CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 645 enrolled
Drug / intervention
AH-HA Tool in the EPIC EHRother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03935282
NCT03935282N/ACompleted

Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors (AH-HA)

Wake Forest University Health Sciences·interventional·Posted May 2, 2019·Updated Apr 15, 2026

In Brief

A clinical study evaluating AH-HA Tool in the EPIC EHR for Breast Neoplasm and 5 related conditions. Completed, enrolled 645 participants across 12 sites.

Detailed Summary

The objective of this hybrid effectiveness-implementation study is to examine the effects of an EHR-based cardiovascular health assessment tool (AH-HA) among breast, prostate, colorectal, endometrial, and Hodgkin and non-Hodgkin lymphoma cancer survivors (N=600) receiving survivorship care in community oncology practices, using a group-randomized trial design (6 intervention practices and 6 usual care practices). Our central hypothesis is that the AH-HA tool will increase (1) cardiovascular health (CVH) discussions among survivors and oncology providers, (2) referrals and visits to primary care and cardiology (care coordination), and (3) cardiovascular (CV) risk reduction and health promotion activities compared to usual care.

Study Details

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 2, 2019
Enrollment StartOct 1, 2020
Primary CompletionMar 7, 2025
Study CompletionNov 17, 2025
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 7.2 years ago

Interventions

AH-HA Tool in the EPIC EHRother

The Automated Heart-Health Assessment tool implemented in clinics' EPIC EHR will be used by providers during routine follow-up care appointments.